Curcumin attenuates DNB-induced murine colitis.
暂无分享,去创建一个
A. Gomez-Muñoz | B. Salh | K. Assi | D. Owen | K. Jacobson | B Salh | K Assi | V Templeman | K Parhar | D Owen | A Gómez-Muñoz | K Jacobson | K. Parhar | V. Templeman | Valerie Templeman | Ken Parhar | Danny Owen | Antonio Gmez-Muoz
[1] R. Davis,et al. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. , 1997, Journal of immunology.
[2] T. Kishimoto,et al. IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis1 , 2000, The Journal of Immunology.
[3] S. Targan,et al. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .
[4] Judy H. Cho,et al. [Letters to Nature] , 1975, Nature.
[5] M. Su,et al. Interferon‐γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway , 1998, The EMBO journal.
[6] S. Yamamoto,et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor α production in trinitrobenzene sulphonic acid induced colitis , 1997, Gut.
[7] C. Heid,et al. A novel method for real time quantitative RT-PCR. , 1996, Genome research.
[8] T. Kishimoto,et al. IL-6 Is Required for the Development of Th 1 Cell-Mediated , 2000 .
[9] R. Thompson,et al. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. , 1994, Gastroenterology.
[10] R. Schmid,et al. Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. , 2000, Gastroenterology.
[11] J. Lee,et al. Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. , 1997, Journal of immunology.
[12] M. Chan. Inhibition of tumor necrosis factor by curcumin, a phytochemical. , 1995, Biochemical pharmacology.
[13] C. Elson,et al. Experimental models of inflammatory bowel disease. , 1995, Gastroenterology.
[14] J. C. Jones,et al. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. , 1998, Journal of immunology.
[15] K. Piwocka,et al. Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. , 1997, Biochemical pharmacology.
[16] Mourad Sahbatou,et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.
[17] P. Tak,et al. NF-κB: a key role in inflammatory diseases , 2001 .
[18] D. Hommes,et al. Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. , 2002, Gastroenterology.
[19] W. Fiers,et al. The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.
[20] S. Hanauer. INFLAMMATORY BOWEL DISEASE , 2005, The American Journal of Gastroenterology.
[21] M. Peppelenbosch,et al. Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis , 2002, Gut.
[22] C. Nast,et al. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. , 1994, The Journal of clinical investigation.
[23] H. Lander. An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] M. Dowsett,et al. Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] B. Aggarwal,et al. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. , 1995, The Journal of biological chemistry.
[26] P. Rutgeerts,et al. Prevention of Experimental Colitis in SCID Mice Reconstituted with CD45RBhigh CD4+ T Cells by Blocking the CD40-CD154 Interactions1 , 2000, The Journal of Immunology.
[27] K. Mchugh,et al. The mechanism of altered neural function in a rat model of acute colitis. , 1997, Gastroenterology.
[28] D. Polk,et al. Aminosalicylic Acid Inhibits IκB Kinase α Phosphorylation of IκBα in Mouse Intestinal Epithelial Cells* , 1999, The Journal of Biological Chemistry.
[29] S. Saccani,et al. p38-dependent marking of inflammatory genes for increased NF-κB recruitment , 2002, Nature Immunology.
[30] M. Kagnoff,et al. Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium. , 2002, Gastroenterology.
[31] F. Dumont,et al. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. , 1999, Cellular immunology.
[32] H. Ammon,et al. Pharmacology of Curcuma longa , 1991, Planta medica.
[33] R. Sartor,et al. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. , 1994, Gastroenterology.
[34] S. Targan,et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. , 1997, The New England journal of medicine.
[35] D. Brenner,et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.
[36] C. Rao,et al. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. , 1995, Cancer research.
[37] A. Conney,et al. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. , 1991, Cancer research.
[38] M. Neurath,et al. Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice , 1996, Nature Medicine.
[39] Philip Rosenstiel,et al. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. , 2002, Journal of immunology.
[40] R. Sartor. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. , 1995, Gastroenterology clinics of North America.
[41] E. Mazzon,et al. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis. , 2000, European journal of pharmacology.
[42] C. Nelson,et al. The p38 mitogen‐activated protein kinase regulates interleukin‐1β‐induced IL‐8 expression via an effect on the IL‐8 promoter in intestinal epithelial cells , 2003, Immunology.
[43] B. Aggarwal,et al. Curcumin (Diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. , 1998, Biochemical pharmacology.
[44] Philip Rosenstiel,et al. p38 Mitogen-Activated Protein Kinase Is Activated and Linked to TNF-α Signaling in Inflammatory Bowel Disease1 , 2002, The Journal of Immunology.
[45] S. V. van Deventer. Tumour necrosis factor and Crohn's disease. , 1997, Gut.
[46] M. Levite,et al. Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. , 2000, Journal of immunology.
[47] J. Wallace. Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. , 1987, Prostaglandins.
[48] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[49] J. Woodgett,et al. The stress-activated protein kinase pathways , 1999, Cellular and Molecular Life Sciences CMLS.
[50] M. Levite,et al. Somatostatin Through Its Specific Receptor Inhibits Spontaneous and TNF-α- and Bacteria-Induced IL-8 and IL-1β Secretion from Intestinal Epithelial Cells1 , 2000, The Journal of Immunology.
[51] R. Sartor,et al. The IκB/NF-κB system: a key determinant of mucosal inflammation and protection , 2000 .
[52] T. Tan,et al. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin , 1998, Oncogene.
[53] J. Wallace,et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. , 1989, Gastroenterology.
[54] K. Madsen,et al. MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. , 2002, American journal of physiology. Cell physiology.
[55] P. Tak,et al. NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.
[56] J. Wallace,et al. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. , 1995, The American journal of physiology.
[57] S. Saccani,et al. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. , 2002, Nature immunology.
[58] R. Schmid,et al. Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β , 2000 .
[59] H. Ohshima,et al. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. , 1995, Biochemical and biophysical research communications.
[60] S. Targan,et al. The Role of Chemokines and Chemokine Receptors in Mucosal Inflammation , 2000, Inflammatory bowel diseases.
[61] R. Schmid,et al. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. , 1998, The Journal of clinical investigation.
[62] S. Hwang,et al. Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. , 1999, European journal of pharmacology.
[63] T. Rao,et al. Anti-inflammatory activity of curcumin analogues. , 1982, The Indian journal of medical research.